- Tuesday, May 18th2:00 p.m. ET -

MISSISSAUGA, ON, May 11, 2021 /PRNewswire/ - Nuvo Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Miravo's President & Chief Executive Officer and Mary-Jane Burkett, Miravo's Vice President & Chief Financial Officer will be presenting at the Q2 Virtual Investor Summit. 

Miravo Healthcare Logo (CNW Group/Nuvo Pharmaceuticals Inc.)

DATE: 

Tuesday, May 18,, 2021

TIME: 

2:00 p.m. ET

COMPLIMENTARY
 REGISTRATION:
 

https://zoom.us/webinar/register/WN_KHDIM1GmQi6On6OA6gAZ6w 

About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.  The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors. 
Please visit the website at www.investorsummitgroup.com

About Miravo Healthcare
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products.  The Company's products target several therapeutic areas, including pain, allergy, neurology and dermatology.  The Company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.  Miravo's head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company's manufacturing facility is located in Varennes, Québec, Canada.  The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration.  For additional information, please visit www.miravohealthcare.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-to-present-at-q2-virtual-investor-summit-301288267.html

SOURCE Nuvo Pharmaceuticals Inc.

Copyright 2021 PR Newswire

Nuvo Pharmaceuticals (TSX:MRV)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Nuvo Pharmaceuticals Charts.
Nuvo Pharmaceuticals (TSX:MRV)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Nuvo Pharmaceuticals Charts.